Anand Varadan
2018 - Karyopharm Therapeutics
In 2018, Anand Varadan earned a total compensation of $2.3M as Executive Vice President, Chief Commercial Officer at Karyopharm Therapeutics.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $102,263 |
| Option Awards | $1,951,950 |
| Salary | $211,846 |
| Other | $11,358 |
| Total | $2,302,417 |
Varadan received $2M in option awards, accounting for 85% of the total pay in 2018.
Varadan also received $25K in bonus, $102.3K in non-equity incentive plan, $211.8K in salary and $11.4K in other compensation.
Rankings
In 2018, Anand Varadan's compensation ranked 5,022nd out of 14,244 executives tracked by ExecPay. In other words, Varadan earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,022 out of 14,244 | 65th |
Division Manufacturing | 1,886 out of 5,759 | 67th |
Major group Chemicals And Allied Products | 692 out of 2,122 | 67th |
Industry group Drugs | 579 out of 1,811 | 68th |
Industry Pharmaceutical Preparations | 445 out of 1,385 | 68th |
Source: SEC filing on April 19, 2019.
Varadan's colleagues
We found four more compensation records of executives who worked with Anand Varadan at Karyopharm Therapeutics in 2018.